Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Multiple System Atrophy (MSA) With Orthostatic Hypotension”

14 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 14 of 14 results

Large-scale testing (Phase 3)Study completedNCT03750552
What this trial is testing

Clinical Effect of Ampreloxetine (TD-9855) for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 195
Not applicableLooking for participantsNCT06920134
What this trial is testing

Epidural Electrical Stimulation to Support Hemodynamic Management in Individuals With Parkinson's Disease

Who this might be right for
Hypotension SymptomaticParkinson's DiseaseOrthostatic Hypotension, Dysautonomic+2 more
Ecole Polytechnique Fédérale de Lausanne 5
Large-scale testing (Phase 3)Study completedNCT02071459
What this trial is testing

Efficacy of L-threo DOPS on Orthostatic Hypotension Symptoms and Other Non-motor Symptoms in Patients With MSA

Who this might be right for
Multiple System Atrophy
University Hospital, Toulouse 107
Not applicableLooking for participantsNCT06647641
What this trial is testing

The CurePSP Genetics Program

Who this might be right for
PSPPSP - Progressive Supranuclear PalsyCorticobasal Syndrome+17 more
Massachusetts General Hospital 1,000
Testing effectiveness (Phase 2)Study completedNCT02705755
What this trial is testing

TD-9855 Phase 2 in Neurogenic Orthostatic Hypotension (nOH)

Who this might be right for
Neurogenic Orthostatic HypotensionMultiple System Atrophy (MSA) With Orthostatic HypotensionPure Autonomic Failure+5 more
Theravance Biopharma 34
Large-scale testing (Phase 3)Study completedNCT00633880
What this trial is testing

Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 181
Large-scale testing (Phase 3)Study completedNCT00782340
What this trial is testing

A Clinical Study for Patients With Neurogenic Orthostatic Hypotension (NOH) Using Droxidopa

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Non-diabetic NeuropathyPrimary Autonomic Failure+1 more
Chelsea Therapeutics 263
Large-scale testing (Phase 3)Study completedNCT00738062
What this trial is testing

Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)

Who this might be right for
Neurogenic Orthostatic HypotensionNon-Diabetic Autonomic NeuropathyMultiple System Atrophy+1 more
Chelsea Therapeutics 103
Large-scale testing (Phase 3)Ended earlyNCT01927055
What this trial is testing

A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionParkinson's DiseaseMultiple Systems Atrophy+2 more
Chelsea Therapeutics 61
Very early researchStudy completedNCT04616456
What this trial is testing

Effect of Verdiperstat on Microglial Activation in Well-characterized MSA Patients

Who this might be right for
Multiple System AtrophyMultiple System Atrophy, Cerebellar VariantMultiple System Atrophy, Parkinson Variant (Disorder)+1 more
Brigham and Women's Hospital 19
Testing effectiveness (Phase 2)UnknownNCT00758849
What this trial is testing

Fipamezole in Neurogenic Orthostatic Hypotension

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension (NOH)Parkinson's DiseaseMultiple System Atrophy
Juvantia Pharma Ltd 24
Large-scale testing (Phase 3)Ended earlyNCT03829657
What this trial is testing

Phase 3 Clinical Effect Durability of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSAParkinson's Disease (PD)+1 more
Theravance Biopharma 203
Large-scale testing (Phase 3)Active Not RecruitingNCT05696717
What this trial is testing

Phase 3 Efficacy and Durability of Ampreloxetine for the Treatment of Symptomatic nOH in Participants With Multiple System Atrophy

Who this might be right for
Symptomatic Neurogenic Orthostatic HypotensionMSA - Multiple System Atrophy
Theravance Biopharma 102
Large-scale testing (Phase 3)Ended earlyNCT04095793
What this trial is testing

Phase 3 Open-Label Extension Study of TD-9855 for Treating Symptomatic nOH in Subjects With Primary Autonomic Failure

Who this might be right for
Symptomatic Neurogenic Orthostatic Hypotension
Theravance Biopharma 110